Literature DB >> 9674808

Spinal cord atrophy and disability in MS: a longitudinal study.

V L Stevenson1, S M Leary, N A Losseff, G J Parker, G J Barker, Y Husmani, D H Miller, A J Thompson.   

Abstract

OBJECTIVE: To assess whether it is possible to measure changes in cord cross-sectional area during a 1-year period in patients with MS reliably.
BACKGROUND: Involvement of the spinal cord in MS is extremely common and an important element in the development of disability. Although little relation has been shown between the cord lesion load and disability, a strong correlation between spinal cord atrophy and the expanded disability status scale (EDSS) has been demonstrated in cross-sectional studies.
METHOD: A highly reproducible semiautomated technique that measures the cross-sectional area of the cord at the C2 level was applied to 13 healthy control subjects and 28 patients serially.
RESULTS: This study confirms that patients have significantly smaller cords than control subjects at baseline (control subjects: mean 80.95 mm2, patients: mean 71.25 mm2, p = 0.01) and demonstrates that patients have a significant loss in cord cross-sectional area during 12 months, which was not seen in control subjects (p < 0.001). This reduction in cord size was most marked in the primary progressive patients who had a mean cord cross-sectional area loss of 3.52 mm2 (5.2%) and least in the secondary progressive (-0.26 mm2, 0.7%) and benign patients (-0.41 mm2, 0.8%). The baseline cord cross-sectional area correlated strongly with the EDSS (r = -0.52, p = 0.005) and with disease duration (r = -0.75, p < 0.001); however, there was no significant difference in cord area (p = 0.69) or change in cord area (p = 0.51) between those patients with a definite increase in EDSS and those without.
CONCLUSION: This study demonstrates, for the first time, that it is possible to measure changes in cord cross-sectional area over time. The serial measurement of spinal cord atrophy may thus make an important contribution to the evaluation of therapeutic efficacy, especially in primary progressive disease.

Entities:  

Mesh:

Year:  1998        PMID: 9674808     DOI: 10.1212/wnl.51.1.234

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  52 in total

1.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis.

Authors:  D B McGavern; P D Murray; C Rivera-Quiñones; J D Schmelzer; P A Low; M Rodriguez
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

Review 2.  Neurological rehabilitation: from mechanisms to management.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

3.  Accurate quantification methods to evaluate cervical cord atrophy in multiple sclerosis patients.

Authors:  J Carbonell-Caballero; J V Manjón; L Martí-Bonmatí; J R Olalla; B Casanova; M de la Iglesia-Vayá; F Coret; M Robles
Journal:  MAGMA       Date:  2006-11-18       Impact factor: 2.310

4.  Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis.

Authors:  Carsten Lukas; Horst K Hahn; Barbara Bellenberg; Jan Rexilius; Gebhard Schmid; Sebastian K Schimrigk; Horst Przuntek; Odo Köster; Heinz-Otto Peitgen
Journal:  Neuroradiology       Date:  2004-11-05       Impact factor: 2.804

Review 5.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

6.  Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?

Authors:  Kerstin Hackmack; Martin Weygandt; Jens Wuerfel; Caspar F Pfueller; Judith Bellmann-Strobl; Friedemann Paul; John-Dylan Haynes
Journal:  J Neurol       Date:  2012-03-24       Impact factor: 4.849

7.  A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis.

Authors:  J Furby; T Hayton; D Altmann; R Brenner; J Chataway; K J Smith; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2010-05-01       Impact factor: 4.849

8.  Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.

Authors:  M Théaudin; G Saliou; B Ducot; K Deiva; C Denier; D Adams; D Ducreux
Journal:  Neuroradiology       Date:  2012-06-26       Impact factor: 2.804

9.  1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.

Authors:  J Suhy; W D Rooney; D E Goodkin; A A Capizzano; B J Soher; A A Maudsley; E Waubant; P B Andersson; M W Weiner
Journal:  Mult Scler       Date:  2000-06       Impact factor: 6.312

10.  Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.

Authors:  M P Sampat; A M Berger; B C Healy; P Hildenbrand; J Vass; D S Meier; T Chitnis; H L Weiner; R Bakshi; C R G Guttmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-20       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.